Lv31
330 积分 2024-07-26 加入
Targeting ROS in cancer: rationale and strategies
2个月前
已完结
The role of ROS in tumour development and progression
2个月前
已完结
Molecular Chameleon Carriers for Nucleic Acid Delivery: The Sweet Spot between Lipoplexes and Polyplexes
2个月前
已完结
Overcoming Endosomal Escape Barriers in Gene Drug Delivery Using De Novo Designed pH-Responsive Peptides
2个月前
已完结
Co‐Delivery of siNRF2 and Sorafenib by a “Click” Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma
2个月前
已完结
RNA interference in the era of nucleic acid therapeutics
2个月前
已完结
RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges
2个月前
已完结
Unprotonatable and ROS‐Sensitive Nanocarrier for NIR Spatially Activated siRNA Therapy with Synergistic Drug Effect
3个月前
已完结
Reversal of Chemoresistance via Staged Liberation of Chemodrug and siRNA in Hierarchical Response to ROS Gradient
3个月前
已完结
Peptidyl Virus‐Like Nanovesicles as Reconfigurable “Trojan Horse” for Targeted siRNA Delivery and Synergistic Inhibition of Cancer Cells
3个月前
已完结
皖公网安备34019202002308
